The increase in the development of Highly Hazardous Active Pharmaceutical Ingredients (HAPI) and consequently more restrictive regulations in terms of operators and environmental safety have brought a significant growth in the demand of process containment installations worldwide. 

With hundreds of installations for dispensing, blending, granulation, tableting, capsule filling, coating, washing, tablet counting, blistering up to 5 OEB products, both for production and R&D applications, IMA has a wide and constant knowledge of processing highly potent products.

Containment installations must be designed on a risk based approach. A preliminary risk assessment has to be carried out to identify criticalities, considering the product features, the pharmaceutical requirements of the process to be performed and the plant conditions in terms of regulations, layout and industrial target. 

IMA is aware that containment has to be approached as a global engineering issue in a manufacturing plant. If you are thinking of contained Solid Dose production, IMA is the ideal partner for the development of technical innovations and dedicated solutions to your specific needs.